Phenylpentadienoyl derivatives and their use as par 1 antagonists

Details for Australian Patent Application No. 2007263049 (hide)

Owner Pierre Fabre Medicament

Inventors Letienne, Robert; Le Grand, Bruno; Lamothe, Marie; Perez, Michel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007263049 (Modified Examination)

PCT Pub. Number WO2007/147822

Priority 0605418 19.06.06 FR

Filing date 19 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 27 October 2011

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/10 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/147822 Priority application(s): WO2007/147822

27 October 2011 Application Accepted

  Published as AU-B-2007263049 (Modified Examination)

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263051-Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists

2007263043-Insulinotropic peptide synthesis